Skip to main content
Equibles
MASS logo

MASS · 908 Devices Inc.

Track MASS — free

Use MASS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$10.05 +0.01 (+0.10%)
Russell 2000 member Rebalance outlook locked
Market Cap
$412.92M
Shares
41.33M

MASS metrics

63 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.04
Market cap
$412.92M

Price action

19 metrics
Price change (1W)
-9.5%
Price change (30D)
+19.4%
Price change (3M)
+13.8%
Price change (6M)
+48.7%
Price change (YTD)
+91.2%
Price change (1Y)
+81.9%
Trailing year
Price change (5Y)
-74.3%
52-week high
$11.10
52-week low
$5.09
Change from 52-week high
-9.5%
Change from 52-week low
+97.2%
Annualized volatility
62.8%
Beta
1.4
RSI (14D)
53.1
Price vs SMA 50
+13.0%
Price vs SMA 200
+38.4%
Avg volume (3M)
382,483
Relative volume
0.8
Average dollar volume
$3.50M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
41.33M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.8×
reciprocal yield 14.7%
P / book
3.3
reciprocal yield 30.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
276.9
reciprocal yield 0.4%
Earnings yield
-8.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
52.2%
Operating margin
-64.0%
Trailing 12 months
Net margin
-57.0%
Gross profit (TTM)
$31.73M
Operating profit (TTM)
−$38.93M
Net income (TTM)
−$34.66M
Trailing 12 months
Diluted EPS (TTM)
$-0.96
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$5.10

Growth

11 metrics
Revenue growth YoY
+23.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$60.84M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.2%
Year over year · more shares
Revenue CAGR (3Y)
+6.2%
Revenue CAGR (5Y)
+15.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-27.3%
Return on assets
-17.5%
Debt / equity
—
Current ratio
2.7
EBITDA (TTM)
−$34.23M
Free cash flow (TTM)
—
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$63.02M
Total assets
$197.54M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.49M
Capital expenditures (TTM)
—
R&D (TTM)
$14.41M
SG&A (TTM)
$38.98M
Stock compensation (TTM)
$9.86M
R&D / revenue
23.7%
Stock compensation / revenue
16.2%

Ownership (13F)

3 metrics
13F filers
111
13F filer change QoQ
-1
Institutional ownership
67.7%

Short interest

3 metrics
Short interest
6.8%
Latest settlement · 5.1 days to cover
Days to cover
5.1d
Short-squeeze score
61 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.42M
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1555279 CUSIP 65443P102 13F (30d) 93 filings 91 filers Visit website Investor relations